AK

Ashish Kumar Agrawal

Active Director Director DIN 10142531
DIN 10142531 First appointment May 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Ashish Kumar Agrawal

Data last updated:

Ashish Kumar Agrawal is a Director at Nexnos Pharma Limited (since 2023). The company operates in Healthcare. Nexnos Pharma Limited reported revenue of ₹36.91 Cr (FY 2025).

DIN 10142531
Primary Designation Director
Industry Healthcare
First Appointment 03 May 2023
Oldest Company Age 19 yrs
Largest company Nexnos Pharma Limited · ₹36.91 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nexnos Pharma Limited U24100RJ2007PLC024845
Director03 May 20232007₹36.91 Cr (FY 2025)Active

Board colleagues of Ashish Kumar Agrawal

Directorship timeline

Open interactive timeline →
Nexnos Pharma Limited
Premium access

Shareholding and investment profile for Ashish Kumar Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashish Kumar Agrawal

Ashish Kumar Agrawal currently holds 1 directorship: Nexnos Pharma Limited (Director, since 03 May 2023, revenue ₹36.91 Cr (FY 2025)).

Ashish Kumar Agrawal was first appointed on 03 May 2023 as Director at Nexnos Pharma Limited.

The current boards of Ashish Kumar Agrawal's companies include Kamal Asnani (Nexnos Pharma Limited), Rajesh Peswani (Nexnos Pharma Limited), Rameshchandra (Nexnos Pharma Limited), Vinod Asnani (Nexnos Pharma Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available